April 11-12, 2013
Seaport Hotel, Boston, MA
Pattern recognition receptors (PRRs), such as toll-like receptors (TLRs) and NOD-like receptors, play an important role in recognizing PAMPs and DAMPs (peptides released as inflammatory response), which makes them key effectors of immunity and excellent anti-inflammatory targets for pharmaceutical drug development.
This conference highlights novel developments and emerging opportunities in targeting pattern recognition receptors for health and disease. Coverage will include the therapeutic potential for inflammatory diseases and developing opportunities for infectious diseases and cancer.